David Holman

David H. Holman, Ph.D., is a director in Sterne Kessler’s Biotechnology & Chemical and Trial & Appellate Practice Groups. 

His practice is focused on proceedings before the Patent Trial and Appeal Board (PTAB) and patent strategy. 

With a technical background and training in immunology, microbiology, and molecular biology, David regularly represents leading companies in biotech, pharmaceutical, and chemical industries. 

David’s PTAB practice includes inter partes reviews, post-grant reviews, and interferences, where he counsels clients on initial pre-trial PTAB strategy, briefing and discovery during the PTAB proceeding, appeal, and/or settlement. 

David also regularly counsels clients on global patent preparation and prosecution strategies.